Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 431 participants.
Also called NCT01494987
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 431 participants
- Sponsor
- Registry
-
NCT01494987
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Czechia, Hungary, Malaysia, Poland, Romania, Russia, Serbia, Slovakia, South Africa, Thailand, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT01494987. Randomized; double masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2014-09-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Ranolazine
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Glimepiride
- Intervention (Behavioral)
- Diet
- Intervention (Behavioral)
- Exercise
- Lead sponsor
- Gilead Sciences
Record details
- Record id
cardio:ct-nct01494987- Content hash
5adc1e02bb354d26dc0b5b848e71ec17ba163214f26a8d24f8a864758dbbdc7d